STAT3 in the systemic inflammation of cancer cachexia

TA Zimmers, ML Fishel, A Bonetto - Seminars in cell & developmental …, 2016 - Elsevier
Weight loss is diagnostic of cachexia, a debilitating syndrome contributing mightily to
morbidity and mortality in cancer. Most research has probed mechanisms leading to muscle …

Targeting DNA repair pathways for cancer treatment: what's new?

MR Kelley, D Logsdon, ML Fishel - Future Oncology, 2014 - Taylor & Francis
Disruptions in DNA repair pathways predispose cells to accumulating DNA damage. A
growing body of evidence indicates that tumors accumulate progressively more mutations in …

[HTML][HTML] Inhibition of inflammatory signaling in Tet2 mutant preleukemic cells mitigates stress-induced abnormalities and clonal hematopoiesis

Z Cai, JJ Kotzin, B Ramdas, S Chen, S Nelanuthala… - Cell stem cell, 2018 - cell.com
Inflammation is a risk factor for cancer development. Individuals with preleukemic TET2
mutations manifest clonal hematopoiesis and are at a higher risk of developing leukemia …

Dapagliflozin, a selective SGLT2 Inhibitor, attenuated cardiac fibrosis by regulating the macrophage polarization via STAT3 signaling in infarcted rat hearts

TM Lee, NC Chang, SZ Lin - Free Radical Biology and Medicine, 2017 - Elsevier
During myocardial infarction, infiltrated macrophages have pivotal roles in cardiac
remodeling and delayed M1 toward M2 macrophage phenotype transition is considered one …

Upregulation of PD-L1 and APE1 is associated with tumorigenesis and poor prognosis of gastric cancer

Y Qing, Q Li, T Ren, W Xia, Y Peng, GL Liu… - Drug design …, 2015 - Taylor & Francis
Introduction Gastric cancer is a fatal malignancy with a rising incidence rate. Effective
methods for early diagnosis, monitoring metastasis, and prognosis are currently unavailable …

[HTML][HTML] APE1/Ref-1 as an emerging therapeutic target for various human diseases: phytochemical modulation of its functions

S Thakur, B Sarkar, RP Cholia, N Gautam… - … & molecular medicine, 2014 - nature.com
Abstract Apurinic/apyrimidinic endonuclease 1 (APE1) is a multifunctional enzyme involved
in the base excision repair (BER) pathway, which repairs oxidative base damage caused by …

Two decades of research in discovery of anticancer drugs targeting STAT3, how close are we?

JD Beebe, JY Liu, JT Zhang - Pharmacology & therapeutics, 2018 - Elsevier
Signal transducer and activator of transcription 3 (STAT3) controls many biological
processes including differentiation, survival, proliferation, and angiogenesis. In normal …

[HTML][HTML] Exploiting the Ref-1-APE1 node in cancer signaling and other diseases: from bench to clinic

F Shah, D Logsdon, RA Messmann… - NPJ precision …, 2017 - nature.com
Abstract Reduction-oxidation factor 1-apurinic/apyrimidinic endonuclease (Ref-1/APE1) is a
critical node in tumor cells, both as a redox regulator of transcription factor activation and as …

[HTML][HTML] Is autophagy always a barrier to cisplatin therapy?

J Xu, DA Gewirtz - Biomolecules, 2022 - mdpi.com
Cisplatin has long been a first-line chemotherapeutic agent in the treatment of cancer,
largely for solid tumors. During the course of the past two decades, autophagy has been …

[HTML][HTML] APE1/Ref-1 role in inflammation and immune response

TT Oliveira, LG Coutinho, LOA de Oliveira… - Frontiers in …, 2022 - frontiersin.org
Apurinic/apyrimidinic endonuclease 1/redox effector factor 1 (APE1/Ref-1) is a
multifunctional enzyme that is essential for maintaining cellular homeostasis. APE1 is the …